# Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise

> **NCT04150536** · PHASE1 · COMPLETED · sponsor: **Scilex Pharmaceuticals, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lidocaine topical system 1.8%

## Key facts

- **NCT ID:** NCT04150536
- **Lead sponsor:** Scilex Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-08
- **Primary completion:** 2016-01-25
- **Final completion:** 2016-01-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150536, "Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04150536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*